Development of Chitosan Acetate Films for Transdermal Delivery of Propranolol Hydrochloride
Purpose: To formulate and evaluate chitosan acetate films designed for transdermal delivery of propranolol hydrochloride.
Methods: Chitosan acetate was chemically modified with acetaldehyde and the solution was prepared with 1 % acetic acid, in which was dissolved propranolol hydrochloride, was cast as films in Petri dish and characterised by Fourier transform infrared spectroscopy (FTIR), differential scanning calorimetry (DSC) and nuclear magnetic resonance (NMR). The films were evaluated for permeability, swelling, and in vitro drug release.
Results: Drug content of propranolol hydrochloride in the films ranged from 0.9 to 1.4 mg/cm2 . Swelling was 570 % for chitosan acetate and 180 % for chitosan while drug release through chitosan acetate higher than through chitosan. Permeability coefficient was 6.12 x 10-4 and 0.97 x 10-4 g.cm2 / day for chitosan acetate and chitosan, respectively. FTIR and DSC results indicated that there was no chemical interaction between the drug and the polymers used. NMR spectra showed the appearance of specific peaks for acetate group. Differences between chitosan acetate and chitosan were significant (p < 0.05) with regard to permeability, swelling and in vitro drug release.
Conclusion: The films prepared using the synthesised chitosan acetate exhibited superior physicochemical and drug release characteristics to those of chitosan. The results also indicate chitosan acetate films may be suitable for delivering propranolol hydrochloride via the transdermal route which offers some advantages over other routes.
Keywords: Chitosan, Chitosan acetate, Films, Transdermal route, Propranolol hydrochloride, Permeability.
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.